G
Geron Corporation (GERN)
NMS – Real vaqt narxi. Valyuta: USD
1.32
-0.05 (-3.65%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.32
-0.00 (-0.10%)
Bozordan keyin: Jun 26, 2026, 7:57 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.32
-0.05 (-3.65%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.32
-0.00 (-0.10%)
Bozordan keyin: Jun 26, 2026, 7:57 PM EDT
Geron Corporation, tijorat bosqichidagi biofarmatsevtika kompaniyasi, onkologiya uchun terapevtik mahsulotlarni ishlab chiqishga qaratilgan. Kompaniyaning mahsulotlar qatori quyidagilarni o'z ichiga oladi: RYTELO, transfuzion-bog'liq kamqonlik bilan past-dan o'rtacha-1 xavfli miyelodisplastik sindromlarga chalingan kattalar bemorlarni davolash uchun telomeraza inhibitori; IMerge, past xavfli miyelodisplastik sindromlarni davolash uchun 3-bosqich klinik sinovda; IMpactMF, qaytalangan/refrakter mielofibrozni davolash uchun 3-bosqichda; Impress, yuqori xavfli miyelodisplastik sindromlar va o'tkir miyeloid leykemiyani (OML) davolash uchun 2-bosqich klinik sinovda; IMproveMF, birinchi qator mielofibrozni davolash uchun 1-bosqich klinik sinovda; va IMAGINE, qaytalangan/refrakter OMLni davolash uchun 1/2-bosqich klinik sinovda. Geron Corporation 1990 yilda tashkil etilgan va Foster Siti, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joseph Emile Eid M.D. | Executive VP of Research & Development and Chief Medical Officer |
| Mr. Ahmed ElNawawi | Executive VP & Chief Commercial Officer |
| Mr. Bryan Ridgell | Senior VP of Portfolio & Project Management and Chief of Staff |
| Mr. Harout Semerjian | CEO, President & Director |
| Mr. Shanthakumar Tyavanagimatt | Senior VP & Chief Technical Officer |
| Mr. Timothy Williams J.D. | Executive VP, Chief Legal Officer & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-27 | 8-K | d76653d8k.htm |
| 2026-05-06 | 10-Q | gern-20260331.htm |
| 2026-04-07 | DEFA14A | geroncorporation-schedule1.htm |
| 2026-04-07 | DEF 14A | gern-20260407.htm |
| 2026-04-07 | ARS | ars-annualreporttosecurity.pdf |
| 2026-03-26 | 8-K | d192220d8k.htm |
| 2026-03-02 | S-3ASR | d118024ds3asr.htm |
| 2026-03-02 | 10-K | gern-20251231.htm |
| 2026-02-25 | 8-K | d67820d8k.htm |
| 2026-01-12 | 8-K | gern-20260112.htm |
| Ms. Aron Feingold | Vice President of Investor Relations & Corporate Communications |
| Ms. Dawn Schottlandt CFA | Senior Vice President of Investor Relations & Corporate Affairs |
| Ms. Michelle J. Robertson | EVP, CFO, Treasurer and Principal Financial & Accounting Officer |
| Ms. Shannon T. Odam | Executive VP & Chief People Officer |